Latest Capital Raises News

InVert Graphite Limited has successfully raised $3.5 million and resumed ASX trading following key acquisitions and promising initial trench results at its Morogoro Graphite Project.

Island Pharmaceuticals reported promising Phase 2a/b trial results for its dengue drug ISLA-101 and secured a strategic acquisition of the broad-spectrum antiviral Galidesivir, bolstering its pipeline and balance sheet.

Prospech Limited has reported a 90% increase in its Korsnäs rare earth element resource in Finland, alongside progressing key metallurgical test work and exploring promising copper-gold targets in Slovakia.

SRJ Technologies has taken a strategic leap by acquiring a UAE entity registered with a regional National Oil Company, positioning itself for direct contracting in the Middle East energy sector. This move is supported by a recent capital raise and ongoing restructuring to sharpen its regional focus.

FireFly Metals has identified 325 promising geophysical targets at its Green Bay copper-gold project in Newfoundland, using advanced airborne surveys, and is accelerating drilling with strong financial backing.

Audeara Ltd has reported a landmark FY25 with record cash receipts of $4.9 million, driven by strong domestic sales and expanding global technology partnerships. The company’s strategic R&D and inventory build set the stage for further growth in FY26.

New Murchison Gold Limited has transitioned from explorer to producer with mining underway at its Crown Prince project, backed by a $12 million capital raise and promising high-grade drilling results.

Podium Minerals has significantly expanded its Parks Reef project with a new Copper-Gold Zone resource, increasing the basket price by 18% and completing a $2.6 million oversubscribed capital raise.

Sipa Resources has completed a key drilling program at its South Australian gold projects and secured A$1.6 million in new funding to accelerate exploration activities across multiple sites.

Australian Strategic Materials has successfully closed an oversubscribed Share Purchase Plan, raising nearly A$12 million at a 20% discount to recent market prices.

Deep Yellow Limited reported a quarterly operating cash outflow of A$6.3 million but ended June 2025 with a strong cash position of A$217 million, providing a runway of 24 quarters at current spending levels.

Patrys Limited has announced a fully underwritten entitlement offer to raise approximately $1.77 million, aimed at funding ongoing research and development of its PAT-DX3 therapy and supporting working capital. The offer includes secondary options and shares, subject to shareholder approval, and will significantly expand the company's capital base.